Treviamet (Empagliflozin + Metformin) in Kenya: Product Description

Treviamet is a fixed-dose combination antidiabetic medication containing:

• Empagliflozin (SGLT2 inhibitor) – 5mg or 10mg.
• Metformin (biguanide) – 500mg or 1000mg.

It is used to manage type 2 diabetes mellitus in adults when:

• Metformin alone fails to control blood glucose.
• Dual therapy is needed for enhanced glycemic control.
• Cardiovascular/renal risk reduction is prioritized (empagliflozin protects heart/kidneys).

In Kenya, Treviamet is a modern option for diabetes care, available in major hospitals and pharmacies, though access remains limited due to cost.

Key Benefits:

• Dual action: Metformin reduces liver glucose production; empagliflozin increases urinary glucose excretion.
• Cardio-renal protection: Lowers risk of heart failure hospitalization and CKD progression.
• Weight loss potential (unlike sulfonylureas/insulin).

Frequently Asked Questions (FAQs)

1. What is Treviamet used for?

   • Type 2 diabetes: As add-on to metformin or initial dual therapy.
   • Not for: Type 1 diabetes or diabetic ketoacidosis (DKA).

2. Is Treviamet available in Kenya?

   • Yes, but restricted to specialized pharmacies:
     • Hospitals: Nairobi Hospital, Aga Khan University Hospital, Karen Hospital.
     • Pharmacies: Goodlife (selected branches), Medsafes (Nairobi).
   • Cost: ~KES 3,500–5,000 for 28 tablets (empagliflozin 10mg + metformin 1000mg).

3. How does it differ from metformin alone?

   • Added empagliflozin: Lowers HbA1c by 0.5–0.8% extra, reduces BP, and promotes weight loss.

4. What are the side effects?

   • Common:
     • Genital mycotic infections (e.g., yeast – 5–10% of users).
     • Urinary tract infections (UTIs).
     • GI upset (from metformin – nausea, diarrhea).
   • Serious (seek help):
     • DKA (rare but life-threatening; symptoms: nausea, vomiting, abdominal pain).
     • Lactic acidosis (metformin risk; symptoms: muscle pain, breathing difficulty).
     • Dehydration/hypotension (especially in elderly).

5. Can NHIF cover Treviamet?

   • Partial coverage possible under NHIF’s “Supa Cover” for diabetes if prescribed by an endocrinologist. Requires pre-approval.

How to Use Treviamet

• Dosage:

  Strength	Starting Dose	Max Dose
  Empa 5mg + Met 500mg	1 tab twice daily	2 tabs twice daily
  Empa 10mg + Met 1000mg	1 tab once daily	2 tabs once daily

  • Take with meals to reduce metformin GI side effects.

• Critical Precautions:

  • Kidney Function: Check eGFR before starting. Do not use if eGFR <45 ml/min.
  • Dehydration Risk: Maintain fluid intake; avoid in acute illness (e.g., vomiting/diarrhea).
  • DKA Monitoring: Test ketones if blood glucose >250 mg/dL or symptoms occur.
  • Drug Interactions: Avoid with IV contrast dye (stop 48 hrs before procedure).

• Missed Dose:

  • Take if remembered soon. Skip if near next dose. Do not double.

Composition

• Active Ingredients per Tablet:
  • Empagliflozin: 5mg or 10mg.
  • Metformin HCl: 500mg or 1000mg.
• Inactive Ingredients: Microcrystalline cellulose, povidone, magnesium stearate.
• Packaging: 28 tablets in blister packs.

Conclusion

Treviamet represents a significant advancement in type 2 diabetes management in Kenya, offering combined glucose control with cardio-renal protection. However, its high cost and renal restrictions limit accessibility. For optimal use:

• Prioritize lifestyle changes (diet, exercise) alongside medication.
• Regular monitoring: HbA1c every 3 months, kidney function every 6 months.
• Report side effects early (e.g., genital itching, excessive thirst).

Access & Support in Kenya:

1. Cost-Effective Alternatives:
   • Separate tablets: Empagliflozin (Jardiance) + generic metformin – may be cheaper.
   • Other SGLT2i: Dapagliflozin (Forxiga) + metformin combinations.
2. NHIF Process:
   • Submit endocrinologist’s prescription + recent HbA1c/kidney test results.
   • Co-pay: ~KES 1,500–2,500 after NHIF reimbursement.
3. Diabetes Clinics:
   • Free consultations at Kenya Diabetes Management & Information Centre (KDMI).
   • County Hospitals: Mbagathi, Mama Lucy Kibaki (subsidized SGLT2 inhibitors).

Disclaimer: Not medical advice. SGLT2 inhibitors carry DKA risk. Use only under endocrinologist supervision.

Note: Treviamet may cause false-negative urine glucose tests. Use blood glucose monitoring only.